Antibody industry insights

A Brief Overview of Top Antibody Companies in Canada

Updated on Feb. 7, 2022
less than a minute read
Canada ranks fourth in global health and biosciences hubs, according to measures identified by the U.K. BioIndustry Association. Canadian biotech companies are nimble, dynamic, and focused. In this article, we will take a deep dive into some of the most prominent public biotech companies that are developing antibody products.

For more details of the analysis and reports, please see the published post in Officitial WeChat Account of Chinese Antibody Society.

More stories like this

Therapeutic Antibody Licensing Deals a 2021 End of Year Summary

Fourty antibody deals were closed at a total value of ~ $14.7 billion in 2021. Twenty two of them were in-licensing deals; eighteen were out-licensing deals.

Read Story

Antibody Licensing Deals in China H1 2021 Summary

We are excited to announce that PharmaDJ and the Chinese Antibody Society will collaborate to provide comprehensive analysis and reports about therapeutic antibody licensing deals between Chinese biopharma and overseas companies.

Read Story
Back to Main Posts
This web app is a Python Django project independently coded (frontend+backend+deployment on AWS) by Xin Yu (Github, LinkedIn) in her volunteer capacity at the Chinese Antibody Society. Contents are maintained by CAS IT team. If you're interested in participating in the future development of this web app, please submit a volunteer application and request an interview with the IT team. We require a minimum of 2 years experience as a Django developer. © Chinese Antibody Society 2021. All Rights Reserved. Legal Disclaimer